RespiVert

Acquired by Centocor Ortho Biotech
Developing innovative inhaled therapies for severe respiratory diseases.

Investment Team

Sector

Life Sciences

Category

Therapeutics

Location

London, UK

Initial Investment

2007
Developing innovative inhaled therapies for severe respiratory diseases.

RespiVert was a drug discovery and development company focused on inhaled therapies for severe respiratory disease. RespiVert was acquired by Centocor Ortho Biotech – a division of Johnson & Johnson.